| Patents for C07D 409 - Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms (52,226) |
|---|
| 09/21/2000 | CA2368122A1 Novel compounds and compositions as protease inhibitors |
| 09/21/2000 | CA2367595A1 Lxr modulators |
| 09/21/2000 | CA2367461A1 Heterocyclic aromatic compounds useful as growth hormone secretagogues |
| 09/20/2000 | EP1036793A2 A process for preparing 2-alkyl-3-aminothiophene derivative and 3-aminothiophene derivative |
| 09/20/2000 | EP1036072A1 Thrombin receptor antagonists |
| 09/20/2000 | EP1036067A2 Pdgf receptor kinase inhibitory compounds, their preparation and compositions |
| 09/20/2000 | EP1036065A1 Substituted imidazole derivatives having agonist-like activity at alpha 2b or 2b/2c adrenergic receptors |
| 09/20/2000 | EP1036063A1 Heteroaryl aminoguanidines and alkoxyguanidines and their use as protease inhibitors |
| 09/20/2000 | CN1267300A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs useful for inhibition of farnesyl protein transferase |
| 09/20/2000 | CN1267299A Aminooxyamide tricyclic inhibitors of farnesylprotein transferase |
| 09/20/2000 | CN1267293A Benzo (5,6) cyclohepta (1,2-b) pyridine derivs. useful for inhibition of farnesyl-protein transferase |
| 09/19/2000 | US6121309 Fused-ring carboxylic acid derivatives |
| 09/19/2000 | US6121308 Indole and benzimidazole antithrombotic compounds, such as 1-methyl-2-(n-(4-amidinophenyl)-aminomethyl)-5-(n-(hydroxycarbonylmethyl) -quinoline-8-sulphonylamino)-indole |
| 09/19/2000 | US6121293 Benzothiophene compounds, compositions, and methods |
| 09/19/2000 | US6121283 N-substituted-6-(2-(4-trifluoromethylphenyl)phenylcarbonyl-amino) -1,2,3,4-tetrahydroisoquinolines; treating disorders including obesity, hyperlipidemia, and diabetes; microsomal triglyceride transfer protein (mtp); apolipoprotein b (apo-b) |
| 09/19/2000 | US6121271 Antidiabetic agents |
| 09/19/2000 | US6121267 Substituted piperazines and piperidines as central nervous system agents |
| 09/19/2000 | US6121260 Appetite stimulation with dosage of neuropeptide y (npy) receptor agonist |
| 09/19/2000 | US6121258 For treatment of arthritis, cancer, cardiovascular disorders, skin disorders, ocular disorders, inflammation, gum disease |
| 09/19/2000 | US6121204 Selective control of monocotyledonous and dicotyledonous weeds in monocotyledonous and dicotyledonous crops, both pre-emergence and post-emergence |
| 09/19/2000 | US6121202 2-((thienyl or furyl) (oxy or thio))-pyridine and 6-((thienyl or furyl) (oxy or thio))-pyrimidine compounds |
| 09/19/2000 | US6120696 Proton conductors in liquid form |
| 09/14/2000 | WO2000053580A2 N-protected synthesis method for use in making porphyrins |
| 09/14/2000 | WO2000053573A1 Medicinal compositions with [2.2.1] and [3.1.1] bicycloskeleton antagonistic to both of pgd2/txa2 receptors |
| 09/14/2000 | WO2000053282A1 Crystallization process for producing fine crystal products |
| 09/14/2000 | WO2000037469A3 Process for preparing n6-substituted deaza-adenosine derivatives |
| 09/14/2000 | WO2000037422A3 Ion channel modulating agents |
| 09/14/2000 | WO2000022129A9 Non-endogenous, constitutively activated human g protein-coupled receptors |
| 09/13/2000 | EP1035121A1 Pyrrole derivatives, film-forming material and method of preparing the derivatives |
| 09/13/2000 | EP1035113A2 Process for the preparation of 2-aryl-5-(perfluoroalkyl)pyrrole compounds from N-[1-chloro-1-(perfluoroalkyl)methyl]arylimidoyl chloride compounds |
| 09/13/2000 | EP1034167A1 Alpha-alkylthio substituted pyrimidine ethers and thioethers as viral reverse transcriptase inhibitors |
| 09/12/2000 | US6117987 Alkyl or aryl substituted dihydronaphthalene derivatives having retinoid and/or retinoid antagonist like biological activity |
| 09/12/2000 | US6117898 Bicyclic amidine derivatives as inhibitors of nitric oxide synthetase |
| 09/12/2000 | US6117874 Benzopyran and benzo-fused compounds, their preparation and their use as leukotriene B4 (LTB4 ) antagonists |
| 09/12/2000 | US6117869 Compounds for and methods of inhibiting matrix metalloproteinases |
| 09/12/2000 | US6117866 For inhibiting platelet aggregation or clot formation and reocclusion of an artery or vein in a mammal following fibrinolytic therapy or angioplasty; for treating stroke, transient ischemia attacks, or myocardial infarction |
| 09/12/2000 | CA2105384C Treatment of addiction to drugs and substances of abuse |
| 09/12/2000 | CA2047773C Derivatives of benzofuran, benzothiophene, indole and indolizine, process for their preparation as well as the compositions containing them |
| 09/09/2000 | CA2300412A1 Process for the preparation of 2-aryl-5-(perfluoro-alkyl) pyrrole compounds from n-[1-chloro-1-(perfluoroalkyl) methyl] arylimidoyl chloride compounds |
| 09/08/2000 | WO2000051986A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/08/2000 | WO2000051610A1 Pyrrolidine modulators of chemokine receptor activity |
| 09/08/2000 | WO2000051609A1 3-alkyl substituted pyrrolidine modulators of chemokine receptor activity |
| 09/08/2000 | WO2000051608A1 3-thienyl and 3-furanyl pyrrolidine modulators of chemokine receptor activity |
| 09/08/2000 | WO2000051607A1 3-cyclopropyl and 3-cyclobutyl pyrrolidine modulators of chemokine receptor activity |
| 09/08/2000 | CA2330541A1 Cyclopentanone dihydropyridine compounds useful as potassium channel openers |
| 09/06/2000 | EP1032559A1 Aminoalkylphenol derivatives and related compounds |
| 09/06/2000 | EP1032556A1 Pharmaceutically active compounds and methods of use |
| 09/06/2000 | EP1032393A1 QUINOLINE-CONTAINING $g(a)-KETOAMIDE CYSTEINE AND SERINE PROTEASE INHIBITORS |
| 09/06/2000 | CN1265658A 5-naphthalen-1-yl-1,3-dioxane derivatives, preparation and therapeutic application |
| 09/06/2000 | CN1265656A O-substituted hydroxycumaranone derivatives as anttumor and antimetastatic agents |
| 09/06/2000 | CN1265654A 1-(N-phenylaminoalkyl)-piperazine derivatives substituted at position 2 of phenyl ring |
| 09/06/2000 | CN1265649A Indole derivatives as MCP-1 receptor antagonists |
| 09/06/2000 | CN1265591A Coumpound |
| 09/06/2000 | CN1265394A Compound as intermediates for use in preparation of optically active 2-imidazoline-5-one or 2-imidazoline-5-thionone derivatives |
| 09/06/2000 | CN1056144C New use of 6-heterocyclic-4-amino-3,4,5-tetrahydrobenz (CD) indoles compound |
| 09/06/2000 | CN1056143C Piperidine derivatives and its use |
| 09/05/2000 | US6114374 2-and 2,5-substituted phenylketoenols |
| 09/05/2000 | US6114371 3-(cyclohexanoheteroarylidenyl)-2-indolinone protein tyrosine kinase inhibitors |
| 09/05/2000 | US6114360 Pyrrole compounds |
| 09/05/2000 | US6114359 Endothelin receptor antagonists |
| 09/05/2000 | US6114354 N-substituted azaheterocyclic compounds |
| 09/05/2000 | US6114335 Benzoylguanidine derivatives, process for their preparation their use in the preparation of medicines |
| 09/05/2000 | US6114334 Piperazine derivatives as therapeutic agents |
| 09/05/2000 | US6114330 Substituted 2,4-diaminopyrimidines |
| 09/05/2000 | US6113937 Sustained release sufentanil compositions |
| 09/05/2000 | CA2001160C Pyridine derivatives |
| 08/31/2000 | WO2000050470A2 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 08/31/2000 | WO2000050419A1 Substituted bicyclic heterocycles and the use thereof as thrombin inhibitors |
| 08/31/2000 | WO2000050405A1 Quinoline derivatives as tyrosine kinase inhibitors |
| 08/31/2000 | WO2000050396A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 08/31/2000 | WO2000050395A1 Sulfonamide-containing indole compounds |
| 08/31/2000 | WO2000050390A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 08/31/2000 | WO2000012074A3 Use of piperidines and/or piperazines as inhibitors of p38-alpha kinase |
| 08/31/2000 | WO2000007996A3 Pyrazoles as estrogen receptor modulators |
| 08/31/2000 | DE19907813A1 Substituierte bicyclische Heterocyclen, deren Herstellung und deren Verwendung als Arzneimittel Substituted bicyclic heterocycles, their preparation and their use as medicaments |
| 08/31/2000 | CA2371876A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor |
| 08/31/2000 | CA2364804A1 N-substituted arylsulfonylamino hydroxamic acids useful as inhibitors of c-proteinase and for treating or preventing disorders related to unregulated collagen production |
| 08/31/2000 | CA2363628A1 Catalysts containing n-pyrrolyl substituted nitrogen donors |
| 08/30/2000 | EP1031572A1 Pyridylpyrrole derivatives |
| 08/30/2000 | EP1031563A1 Sulfonyl derivatives |
| 08/30/2000 | EP1030844A1 Compounds which inhibit tryptase activity |
| 08/30/2000 | EP1030843A1 Substituted benzene compounds, process for their preparation, and herbicidal and defoliant compositions containing them |
| 08/30/2000 | EP1030840A1 Cyclic amine derivatives and their use as drugs |
| 08/30/2000 | EP1030835A2 Urea derivatives and their use as integrin inhibitors |
| 08/30/2000 | EP0821680B1 Novel taxoids, preparation thereof, and pharmaceutical compositions containing same |
| 08/30/2000 | EP0710367B1 Photochromic substituted naphthopyran compounds |
| 08/30/2000 | EP0690843B1 Formyl- or cyano- substituted indole derivatives having dopaminergic activity |
| 08/30/2000 | CN1265107A Indole and 2,3-dihydronindole derivatives, their prepn. and use |
| 08/30/2000 | CN1265106A Compounds derived from thophene and benzothiophene, and related utilisation and compsn. |
| 08/30/2000 | CN1265033A Certain diarylimidaozle derivatives, new class of NPY speific ligands |
| 08/29/2000 | US6110959 Carboxylic acid derivatives having fused rings |
| 08/29/2000 | US6110953 A therapeutic drug mixture comprising a 1h-1,2,4-triazole with a chemotherapeutic agents can both reduce and suppress the growth of cancers, tumors and leukemia; synergistic effect |
| 08/29/2000 | US6110947 An analgesic agent for treating stroke, abdominal pain; as antiinflammatory, diuretic, anesthetic or neuroprotective agents |
| 08/29/2000 | US6110943 An antipsychotic agent, antidepressant and anxiolytic agent |
| 08/29/2000 | US6110939 As a substance p antagonists treating tachykinin-mediated disease, asthma, central nervous system disorder |
| 08/29/2000 | US6110936 A bactericide treating a bacterial infection in a warm blooded animal |
| 08/29/2000 | US6110924 Barbituric acid derivatives, processes for their production and pharmaceutical agents containing these compounds |
| 08/29/2000 | US6110910 Antiinflammatory agents, antiarthritic agents, antirheumatic agents, anticarcinogenic agents |
| 08/29/2000 | US6110872 2,4,5-trisubstituted phenylketo-enols for use as pesticides and herbicides |
| 08/29/2000 | US6110871 2-((phenyl, pyridyl or pyrazolyl)(oxy or thio)), 6-((substituted)phenyl)-cyanopyridines; herbicidal activity with the necessary selectivity and enhanced soil degradation |